Q3 2025 Holdings
Filed 2025-11-14 | 440 holdings | $349.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $301.6K | 20,574 | 0.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $303.4K | 10,214 | 0.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $324.3K | 42,730 | 0.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $340.2K | 11,311 | 0.1% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $342.7K | 139,309 | 0.1% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $350.0K | 10,328 | 0.1% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $367.5K | 13,333 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $378.3K | 966 | 0.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $382.3K | 11,722 | 0.1% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $386.5K | 28,008 | 0.1% |
| Gladstone Capital Corp(GLAD) | COM NEW | 376535878 | $387.1K | 17,698 | 0.1% |
| Geron Corp(GERN) | COM | 374163103 | $390.3K | 284,868 | 0.1% |
| MSC Income Fund Inc(MSIF) | COM | 55374X208 | $396.0K | 30,158 | 0.1% |
| Oxford Square Cap Corp(OXSQ) | COM | 69181V107 | $397.4K | 249,916 | 0.1% |
| Uniqure NV(QURE) | SHS | N90064101 | $415.4K | 7,116 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $417.5K | 192,378 | 0.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $417.8K | 4,236 | 0.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $419.7K | 16,248 | 0.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $420.2K | 7,758 | 0.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $421.9K | 1,495 | 0.1% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $424.3K | 42,730 | 0.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $429.6K | 11,892 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $436.2K | 20,441 | 0.1% |
| Main STR Cap Corp(MAIN) | COM | 56035L104 | $436.3K | 6,861 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $439.3K | 10,637 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $440.2K | 3,966 | 0.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $447.5K | 9,059 | 0.1% |
| Whitehorse FIN Inc(WHF) | COM | 96524V106 | $451.2K | 65,196 | 0.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $453.1K | 12,472 | 0.1% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $468.3K | 66,427 | 0.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $470.5K | 3,359 | 0.1% |
| Sound Point Meridian Cap Inc(SPMC) | COMMON STOCK | 83617A108 | $478.1K | 27,559 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $479.1K | 852 | 0.1% |
| Morgan Stanley Direct Lendin(MSDL) | COM SHS | 61774A103 | $487.3K | 30,302 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $499.1K | 3,555 | 0.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $508.0K | 4,183 | 0.1% |
| OFS Cap Corp(OFS) | COM | 67103B100 | $509.7K | 66,286 | 0.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $516.9K | 2,600 | 0.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $517.0K | 12,881 | 0.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $521.5K | 44,306 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $522.1K | 23,073 | 0.1% |
| BCP Investment Corporation(BCIC) | COM NEW | 73688F201 | $528.7K | 45,852 | 0.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $535.0K | 8,717 | 0.2% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $538.9K | 62,153 | 0.2% |
| Monroe Cap Corp(MRCC) | COM | 610335101 | $544.0K | 77,488 | 0.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $544.5K | 6,420 | 0.2% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $547.5K | 1,607 | 0.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $559.1K | 3,167 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $567.6K | 72,025 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $582.1K | 11,208 | 0.2% |